Conventional Joint Supplements (Glucosamine, MSM, Chondroitin): BPC-157 Characteristics: Cellular pathway mechanisms in preclinical research Broader potential applications studied in laboratory settings Research-stage peptide with limited human data Conventional Supplement Characteristics: Decades of human clinical trials Established safety profiles More widely understood and accepted Consideration: Conventional supplements suit those preferring established, evidence-based options
37:43 Dr
Use this decision table to interpret a ferritin result the way a functional medicine care team lead would
In 2024, a task force consisting of physicians, pharmacists, and attorneys conducted an unpublished survey to preserve peptides ahead of the Pharmacy Compounding Advisory Committee (PCAC) meetings on October 29 and 4 December 2024 [269,270]
Researchers should approach any peptide protocol with appropriate caution and medical supervision
Dosing information Usual Adult Dose for Pernicious Anemia: Initial dose: 100 mcg intramuscularly or deep subcutaneous once a day for 6 to 7 days If clinical improvement and reticulocyte response is seen from the above dosing: 100 mcg every other day for 7 doses, then: 100 mcg every 3 to 4 days for 2 to 3 weeks, then: Maintenance dose: 100 to 1000 mcg monthly Duration of therapy: Life Comments: Administer concomitant folic acid if needed
